Infectious Disease
Oncology Clinical Trials Decline During Pandemic
Decline in trial launches could have long-term negative impact, authors say
High Efficacy Reported for Sputnik V COVID-19 Vaccine
Interim analysis of data from phase 3 trial shows 91.6 percent efficacy at 21 days after the first dose of the vaccine
COVID-19 Vaccine Uptake Moderately High for Residents at SNFs
Median of 77.8 percent of residents and 37.5 percent of staff members per facility received one or more doses of COVID-19 vaccine
Oncology Clinical Trials Decline During Pandemic
Decline in trial launches could have long-term negative impact, authors say
AstraZeneca Vaccine Guards Against Severe COVID-19 Illness
Researchers also found that a single dose of the vaccine was 76 percent effective at preventing COVID-19
WHO Team Probing COVID-19 Origins Visits Wuhan Research Center
WHO team has visited hospitals, research institutes, and a traditional wet market linked to many of the first cases
Many Cancer Survivors Have Conditions Linked to Risk for Severe COVID-19 Illness
56.4 percent of cancer survivors report having one or more conditions, with increased prevalence in Black survivors
Biden Administration to Start Shipping COVID-19 Vaccines Directly to U.S. Pharmacies
In addition, starting this week, states are receiving 5 percent more vaccine doses
Severe, Active Atopic Eczema Tied to Increased Mortality Risk
In those with severe atopic eczema, strongest associations seen for infectious, respiratory, and genitourinary causes of death
About Four in 10 U.S. Adults Skipped Medical Care During Pandemic
Some cited fear of COVID-19 and financial reasons
